tetano
Editor, Senior Moderator
J Eur Acad Dermatol Venereol
. 2020 Jun 13.
doi: 10.1111/jdv.16741. Online ahead of print.
Cutaneous Manifestations of Hospitalized COVID-19 Patients: A Report of Six Cases With Clinicopathologic Features and Viral RNA in Situ Hybridization
C Bitar[SUP] 1 [/SUP], M P Chan[SUP] 1 2 [/SUP], P W Harms[SUP] 1 2 [/SUP], D R Fullen[SUP] 1 2 [/SUP], J E Gudjonsson[SUP] 2 [/SUP], M Eshaq[SUP] 2 [/SUP], S Renati[SUP] 2 [/SUP], A B Nikle[SUP] 2 [/SUP], A Allen[SUP] 2 [/SUP], S D Hawkins[SUP] 2 [/SUP], T Huerta[SUP] 2 [/SUP], L Lowe[SUP] 1 2 [/SUP], A A Andea[SUP] 1 2 [/SUP]
Affiliations
Abstract
Novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic on March, 2020.[SUP]1[/SUP] Recalcati et al. reported cutaneous manifestations in 20.4% of COVID-19 patients.[SUP]2[/SUP] We identified six patients (five female, one male) with COVID-19-associated cutaneous manifestations in April 2020 on the inpatient dermatology consultation service. The mean age was 51 years (range, 28-71 years).
Keywords: Coronavirus disease 2019 (COVID-19); cutaneous manifestations; histopathologic features; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); viral RNA in situ hybridization.
. 2020 Jun 13.
doi: 10.1111/jdv.16741. Online ahead of print.
Cutaneous Manifestations of Hospitalized COVID-19 Patients: A Report of Six Cases With Clinicopathologic Features and Viral RNA in Situ Hybridization
C Bitar[SUP] 1 [/SUP], M P Chan[SUP] 1 2 [/SUP], P W Harms[SUP] 1 2 [/SUP], D R Fullen[SUP] 1 2 [/SUP], J E Gudjonsson[SUP] 2 [/SUP], M Eshaq[SUP] 2 [/SUP], S Renati[SUP] 2 [/SUP], A B Nikle[SUP] 2 [/SUP], A Allen[SUP] 2 [/SUP], S D Hawkins[SUP] 2 [/SUP], T Huerta[SUP] 2 [/SUP], L Lowe[SUP] 1 2 [/SUP], A A Andea[SUP] 1 2 [/SUP]
Affiliations
- PMID: 32534469
- DOI: 10.1111/jdv.16741
Abstract
Novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic on March, 2020.[SUP]1[/SUP] Recalcati et al. reported cutaneous manifestations in 20.4% of COVID-19 patients.[SUP]2[/SUP] We identified six patients (five female, one male) with COVID-19-associated cutaneous manifestations in April 2020 on the inpatient dermatology consultation service. The mean age was 51 years (range, 28-71 years).
Keywords: Coronavirus disease 2019 (COVID-19); cutaneous manifestations; histopathologic features; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); viral RNA in situ hybridization.